These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas. Kim YJ; Ketter R; Steudel WI; Feiden W Am J Clin Pathol; 2007 Jul; 128(1):118-25. PubMed ID: 17580279 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215 [TBL] [Abstract][Full Text] [Related]
6. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas. Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284 [TBL] [Abstract][Full Text] [Related]
7. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR; El-Zammar O Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [TBL] [Abstract][Full Text] [Related]
8. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas. Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832 [TBL] [Abstract][Full Text] [Related]
9. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival. Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366 [TBL] [Abstract][Full Text] [Related]
10. Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study. Veras E; Malpica A; Deavers MT; Silva EG Int J Gynecol Pathol; 2009 Jul; 28(4):316-21. PubMed ID: 19483635 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247 [TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomas. Struikmans H; Rutgers DH; Jansen GH; Dullens HF; Oosten L; Tulleken CA; van der Tweel I; Battermann JJ Radiat Oncol Investig; 1999; 7(4):243-8. PubMed ID: 10492165 [TBL] [Abstract][Full Text] [Related]
13. The high mitotic count detected by phospho-histone H3 immunostain does not alter the benign behavior of angiocentric glioma. Li JY; Langford LA; Adesina A; Bodhireddy SR; Wang M; Fuller GN Brain Tumor Pathol; 2012 Jan; 29(1):68-72. PubMed ID: 21892765 [TBL] [Abstract][Full Text] [Related]
14. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach. Capper D; Mittelbronn M; Meyermann R; Schittenhelm J Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865 [TBL] [Abstract][Full Text] [Related]
15. Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa. Gunia S; Kakies C; Erbersdobler A; Koch S; May M J Clin Pathol; 2012 Aug; 65(8):715-20. PubMed ID: 22554964 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival. Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)]. Ebelt J; Neid M; Tannapfel A; Witzigmann H; Hauss J; Köckerling F; Wittekind C Zentralbl Chir; 2000; 125(7):597-601. PubMed ID: 10960968 [TBL] [Abstract][Full Text] [Related]
18. An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis. Blümcke I; Luyken C; Urbach H; Schramm J; Wiestler OD Acta Neuropathol; 2004 May; 107(5):381-8. PubMed ID: 15034726 [TBL] [Abstract][Full Text] [Related]
19. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules. Liu X; Chen N; Wang X; He Y; Chen X; Huang Y; Yin W; Zhou Q J Neuropathol Exp Neurol; 2006 Sep; 65(9):905-13. PubMed ID: 16957584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]